Women (n/%) | 44/28.0 |
---|---|
Age (years) | 68.7 ± 11.5 |
Diabetes (n/%) | 36/23 |
Hypertension (n/%) | 109/69 |
Pulmorary disease (n/%) | 20/13 |
Coronary artery disease (n/%) | 61/39 |
Peripheral arterial disease (n/%) | 23/15 |
Liver cirrhosis (n/%) | 1/1 |
Malignancy (n/%) | 12/8 |
Peak SOFA | 14.9 ± 2.9 |
SAPS-II | 51.9 ± 13.3 |
APACHE-II | 23.8 ± 6.5 |
ICU stay (days, survivors, n = 90) | 17.3 ± 15.1 |
Elective (n/%) | 44/28.0 |
Cardiac surgery (n/%) | 70/44.6 |
Gastrointestinal surgery (n/%) | 30/19.1 |
Vascular surgery (n/%) | 38/24.2 |
Trauma surgery (n/%) | 7/4.5 |
Other surgerya (n/%) | 12/14.9 |
Requiring mechanical ventilation (n/%) | 155/98.7 |
Days on mechanical ventilation (days) | 7.9 (2.6–13.1) |
Vasopressor use (n/%) | 155/98.7 |
Baseline creatinine, n = 137 (μmol/l) | 88 (69–115) |
Baseline eGFR, n = 137 (ml/min/1.73 m2) | 78 ± 24 |
ICU mortality (n/%) | 67/42.7 |
90 day mortality (n/%) | 91/58.0 |
One year mortality (n/%) | 98/62.8 |